Company MultiCell Technologies, Inc. Other OTC
Equities
MCET
US62544S2005
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -.--% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,448 | 0 | 0 | 90.01 % |
Stock B | 1 | 5,000,948,700 | 4,501,353,925 ( 90.01 %) | 0 |
Company contact information
MultiCell Technologies, Inc.
4144 North Central Expressway Suite 600
75204, Dallas
+
Sector
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+46.34% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |